Mapping Biological Activities to Different Types of Molecular Scaffolds: Exemplary Application to Protein Kinase Inhibitors
- PMID: 30334211
- DOI: 10.1007/978-1-4939-8639-2_10
Mapping Biological Activities to Different Types of Molecular Scaffolds: Exemplary Application to Protein Kinase Inhibitors
Abstract
Scaffolds were originally introduced to delineate core structures of active compounds. They are also used to assess the ability of computational methods to identify structurally diverse active compounds. Biological activities of compound series are often mapped to scaffolds. This is done to better understand activity distributions over different structural classes or search for core structures of compounds that are preferentially active against target families of interest. Herein, we describe in detail how such scaffold activity profiles are generated and compare profiles for differently defined scaffolds. As an exemplary application, scaffolds of currently available kinase inhibitors covering the human kinome are analyzed.
Keywords: Bioactive compounds; Compound promiscuity; Core structures; Kinase inhibitors; Scaffolds; Scaffold–activity relationships.
Similar articles
-
Exploring the scaffold universe of kinase inhibitors.J Med Chem. 2015 Jan 8;58(1):315-32. doi: 10.1021/jm501237k. Epub 2014 Sep 16. J Med Chem. 2015. PMID: 25192260
-
Systematic computational identification of promiscuity cliff pathways formed by inhibitors of the human kinome.J Comput Aided Mol Des. 2019 Jun;33(6):559-572. doi: 10.1007/s10822-019-00198-9. Epub 2019 Mar 26. J Comput Aided Mol Des. 2019. PMID: 30915709
-
Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.J Comput Aided Mol Des. 2020 Jan;34(1):1-10. doi: 10.1007/s10822-019-00266-0. Epub 2019 Dec 2. J Comput Aided Mol Des. 2020. PMID: 31792884
-
Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.Med Res Rev. 2017 Mar;37(2):314-367. doi: 10.1002/med.21409. Epub 2016 Oct 24. Med Res Rev. 2017. PMID: 27775829 Review.
-
Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors.Curr Med Chem. 2017;24(42):4838-4872. doi: 10.2174/0929867323666161006113418. Curr Med Chem. 2017. PMID: 27719654 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials